Healthcare provider profile · identity verified

Syed A Sattar, MD

Internal Medicine · FLINT, MI · NPI 1639171150

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	487	146
Amlodipine Besylate	Amlodipine Besylate	467	151
Simvastatin	Simvastatin	463	139
Atorvastatin Calcium	Atorvastatin Calcium	363	111
Levothyroxine Sodium	Levothyroxine Sodium	309	90
Omeprazole	Omeprazole	271	92
Metoprolol Succinate	Metoprolol Succinate	224	68
Ozempic	Semaglutide	192	29
Gabapentin	Gabapentin	189	43
Metoprolol Tartrate	Metoprolol Tartrate	183	59
Olmesartan Medoxomil	Olmesartan Medoxomil	178	51
Lisinopril	Lisinopril	175	51
Metformin Hcl Er	Metformin Hcl	174	53
Potassium Chloride	Potassium Chloride	154	49
Hydrochlorothiazide	Hydrochlorothiazide	147	45
Prednisone	Prednisone	145	104
Montelukast Sodium	Montelukast Sodium	140	44
Tamsulosin Hcl	Tamsulosin Hcl	140	46
Eliquis	Apixaban	124	33
Glimepiride	Glimepiride	123	40
Metformin Hcl	Metformin Hcl	122	35
Furosemide	Furosemide	120	41
Carvedilol	Carvedilol	119	33
Clopidogrel	Clopidogrel Bisulfate	114	36
Duloxetine Hcl	Duloxetine Hcl	109	34
Rosuvastatin Calcium	Rosuvastatin Calcium	105	34
Allopurinol	Allopurinol	98	32
Hydralazine Hcl	Hydralazine Hcl	95	25
Tizanidine Hcl	Tizanidine Hcl	91	44
Tramadol Hcl	Tramadol Hcl	88	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	67	22
Buspirone Hcl	Buspirone Hcl	66	22
Doxycycline Hyclate	Doxycycline Hyclate	65	56
Pantoprazole Sodium	Pantoprazole Sodium	64	20
Meloxicam	Meloxicam	62	32
Famotidine	Famotidine	59	19
Pravastatin Sodium	Pravastatin Sodium	58	19
Atenolol	Atenolol	57	18
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	56	21
Donepezil Hcl	Donepezil Hcl	55	19
Nifedipine Er	Nifedipine	55	17
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	54	17
Albuterol Sulfate Hfa	Albuterol Sulfate	53	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	13
Fluticasone Propionate	Fluticasone Propionate	51	31
Ezetimibe	Ezetimibe	49	15
Escitalopram Oxalate	Escitalopram Oxalate	48	14
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	46	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	12
Jardiance	Empagliflozin	44	13
Quetiapine Fumarate	Quetiapine Fumarate	44	12
Finasteride	Finasteride	43	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	12
Spironolactone	Spironolactone	42	13
Mounjaro	Tirzepatide	41	suppressed
Verapamil Er	Verapamil Hcl	41	suppressed
Calcitriol	Calcitriol	39	13
Triamcinolone Acetonide	Triamcinolone Acetonide	39	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	14
Diclofenac Sodium	Diclofenac Sodium	33	16
Lantus	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Azithromycin	Azithromycin	32	29
Dicyclomine Hcl	Dicyclomine Hcl	32	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	26
Cephalexin	Cephalexin	28	26
Trulicity	Dulaglutide	28	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	26	13
Colchicine	Colchicine	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	12
Baclofen	Baclofen	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Alprazolam	Alprazolam	19	suppressed
Fluconazole	Fluconazole	19	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Clonidine	Clonidine	17	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Primidone	Primidone	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Sertraline Hcl	Sertraline Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Glipizide	Glipizide	14	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Clonidine Hcl	Clonidine Hcl	11	suppressed
Piroxicam	Piroxicam	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error